Literature DB >> 34272252

Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report.

Basil Golding1, Youri Lee1, Hana Golding1, Surender Khurana2.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; immune system diseases; treatment; vaccination

Year:  2021        PMID： 34272252     DOI： 10.1136/annrheumdis-2021-220993

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial.

Authors:  Dominik Schröder; Stephanie Heinemann; Alexandra Jablonka; Frank Müller; Gloria Heesen; Frank Klawonn; Marie Mikuteit; Jacqueline Niewolik; Sandra Steffens; Georg Behrens
Journal:  Eur J Med Res       Date:  2022-06-22       Impact factor: 4.981

Review 2.  Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.

Authors:  Giulio Sansone; Domenico Marco Bonifati
Journal:  J Neurol       Date:  2022-05-03       Impact factor: 6.682

3.  Vulvar Aphthous Ulcers in an Adolescent After Coronavirus Disease 2019 (COVID-19) Vaccination.

Authors:  Stephen M Scott; Veronica Alaniz; Leslie Appiah; Eliza Buyers; Carri Holton; Patricia Huguelet
Journal:  Obstet Gynecol       Date:  2022-08-03       Impact factor: 7.623

4.  Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis.

Authors:  David Reyes-Leiva; Joaquín López-Contreras; Esther Moga; Francesc Pla-Juncà; Elionor Lynton-Pons; Ricardo Rojas-Garcia; Janina Turon-Sans; Luis Querol; Montse Olive; Rodrigo Álvarez-Velasco; Marta Caballero-Ávila; Álvaro Carbayo; Ana Vesperinas-Castro; Pere Domingo; Isabel Illa; Eduard Gallardo; Elena Cortés-Vicente
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.